92 research outputs found
A General Framework for Anytime Approximation in Probabilistic Databases
Anytime approximation algorithms that compute the probabilities of queries
over probabilistic databases can be of great use to statistical learning tasks.
Those approaches have been based so far on either (i) sampling or (ii)
branch-and-bound with model-based bounds. We present here a more general
branch-and-bound framework that extends the possible bounds by using
'dissociation', which yields tighter bounds.Comment: 3 pages, 2 figures, submitted to StarAI 2018 Worksho
Evidence of Ionization Blue Shift Seeding of Forward Raman Scattering
We report on the results of spectroscopic experiments that were conducted by focusing an intense ultra‐short laser pulse onto a helium gas target. The scattered light from the interaction region was measured spectrally and spatially from various directions as a function of laser intensity and plasma density. The experimental data showed that forward Stimulated Raman Scattering (SRS) was sensitive to the focus position of laser relative to the nozzle. Together with the plasma channel that was imaged by a CCD camera, the measurements indicate that SRS is seeded by the ionization blue‐shifted light. The cross‐phase modulation between the SRS and laser beam was also observed in the experiment. © 2004 American Institute of PhysicsPeer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/87541/2/585_1.pd
Dependence of hard x-ray yield on laser pulse parameters in the wavelength-cubed regime
Conversion efficiency and electron temperature scaling laws are experimentally studied in the wavelength-cubed (λ3)(λ3) regime, where a single-wavelength focus allows low energy pulses incident on a Mo target to produce x rays with excellent efficiency and improved spatial coherence. Focused intensity is varied from 2×10162×1016 to 2×1018 W/cm2.2×1018W/cm2. Conversion efficiency and electron temperature are best described by a power law for energy scaling while an exponential law best describes the scaling of these parameters with pulse duration. © 2004 American Institute of Physics.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/69364/2/APPLAB-84-13-2259-1.pd
The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis
To determine whether MDR1 reversal by the addition of the P-glycoprotein
(P-gp) inhibitor PSC-833 to standard induction chemotherapy would improve
event-free survival (EFS), 419 untreated patients with acute myeloid
leukemia (AML) aged 60 years and older were randomized to receive 2
induction cycles of daunorubicin and cytarabine with or without PSC-833.
Patients in complete remission were then given 1 consolidation cycle
without PSC-833. Neither complete response (CR) rate (54% versus 48%; P =
.22), 5-year EFS (7% versus 8%; P = .53), disease-free survival (DFS; 13%
versus 17%; P = .06) nor overall survival (OS; 10% in both arms; P = .52)
were significantly improved in the PSC-833 arm. An integrated P-gp score
(IPS) was determined based on P-gp function and P-gp expression in AML
cells obtained prior to treatment. A higher IPS was associated with a
significantly lower CR rate and worse EFS and OS. There was no significant
interaction between IPS and treatment arm with respect to CR rate and
survival, indicating also a lack of benefit of PSC-833 in P-gp-positive
patients. The role of strategies aimed at inhibitory P-gp and other
drug-resistance mechanisms continues to be defined in the treatment of
patients with AML
Experimental implementation of a silicon wafer tandem solar cell
We combine aluminum back surface field (Al-BSF) solar cell precursors with an additional rear side infrared active floating
emitter in a tandem cell configuration. This emitter is implemented area selectively by fs-laser hyperdoping in a sulfurous atmosphere. Its design as a floating emitter conceals losses induced by the laser process as long as n-doping occurs. All processes are adapted and supplemented by just a single new process step
13C labeling experiments at metabolic nonstationary conditions: An exploratory study
<p>Abstract</p> <p>Background</p> <p>Stimulus Response Experiments to unravel the regulatory properties of metabolic networks are becoming more and more popular. However, their ability to determine enzyme kinetic parameters has proven to be limited with the presently available data. In metabolic flux analysis, the use of <sup>13</sup>C labeled substrates together with isotopomer modeling solved the problem of underdetermined networks and increased the accuracy of flux estimations significantly.</p> <p>Results</p> <p>In this contribution, the idea of increasing the information content of the dynamic experiment by adding <sup>13</sup>C labeling is analyzed. For this purpose a small example network is studied by simulation and statistical methods. Different scenarios regarding available measurements are analyzed and compared to a non-labeled reference experiment. Sensitivity analysis revealed a specific influence of the kinetic parameters on the labeling measurements. Statistical methods based on parameter sensitivities and different measurement models are applied to assess the information gain of the labeled stimulus response experiment.</p> <p>Conclusion</p> <p>It was found that the use of a (specifically) labeled substrate will significantly increase the parameter estimation accuracy. An overall information gain of about a factor of six is observed for the example network. The information gain is achieved from the specific influence of the kinetic parameters towards the labeling measurements. This also leads to a significant decrease in correlation of the kinetic parameters compared to an experiment without <sup>13</sup>C-labeled substrate.</p
Treatment satisfaction and quality-of-life between type 2 diabetes patients initiating long- vs. intermediate-acting basal insulin therapy in combination with oral hypoglycemic agents – a randomized, prospective, crossover, open clinical trial
Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909
T cells with specificity for antigens derived from Wilms Tumor gene (WT1), Proteinase3 (Pr3), and mucin1 (MUC1) have been demonstrated to lyse acute myeloid leukemia (AML) blasts and multiple-myeloma (MM) cells, and strategies to enhance or induce such tumor-specific T cells by vaccination are currently being explored in multiple clinical trials. To test safety and immunogenicity of a vaccine composed of WT1-, Pr3-, and MUC1-derived Class I-restricted peptides and the pan HLA-DR T helper cell epitope (PADRE) or MUC1-helper epitopes in combination with CpG7909 and MontanideISA51, four patients with AML and five with MM were repetitively vaccinated. No clinical responses were observed. Neither pre-existing nor naive WT1-/Pr3-/MUC1-specific CD8+ T cells expanded in vivo by vaccination. In contrast, a significant decline in vaccine-specific CD8+ T cells was observed. An increase in PADRE-specific CD4+ T helper cells was observed after vaccination but these appeared unable to produce IL2, and CD4+ T cells with a regulatory phenotype increased. Taken into considerations that multiple clinical trials with identical antigens but different adjuvants induced vaccine-specific T cell responses, our data caution that a vaccination with leukemia-associated antigens can be detrimental when combined with MontanideISA51 and CpG7909. Reflecting the time-consuming efforts of clinical trials and the fact that 1/3 of ongoing peptide vaccination trails use CpG and/or Montanide, our data need to be taken into consideration
Improving risk management for violence in mental health services: a multimethods approach
contractual_start_date: 07-2008 editorial_review_begun: 07-2014 accepted_for_publication: 06-2015contractual_start_date: 07-2008 editorial_review_begun: 07-2014 accepted_for_publication: 06-2015contractual_start_date: 07-2008 editorial_review_begun: 07-2014 accepted_for_publication: 06-2015contractual_start_date: 07-2008 editorial_review_begun: 07-2014 accepted_for_publication: 06-201
Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants
© The Author(s) 2018. Background: Change in the prevalence of raised blood pressure could be due to both shifts in the entire distribution of blood pressure (representing the combined effects of public health interventions and secular trends) and changes in its high-blood-pressure tail (representing successful clinical interventions to control blood pressure in the hypertensive population). Our aim was to quantify the contributions of these two phenomena to the worldwide trends in the prevalence of raised blood pressure. Methods: We pooled 1018 population-based studies with blood pressure measurements on 88.6 million participants from 1985 to 2016. We first calculated mean systolic blood pressure (SBP), mean diastolic blood pressure (DBP) and prevalence of raised blood pressure by sex and 10-year age group from 20-29 years to 70-79 years in each study, taking into account complex survey design and survey sample weights, where relevant. We used a linear mixed effect model to quantify the association between (probittransformed) prevalence of raised blood pressure and age-group- and sex-specific mean blood pressure. We calculated the contributions of change in mean SBP and DBP, and of change in the prevalence-mean association, to the change in prevalence of raised blood pressure. Results: In 2005-16, at the same level of population mean SBP and DBP, men and women in South Asia and in Central Asia, the Middle East and North Africa would have the highest prevalence of raised blood pressure, and men and women in the highincome Asia Pacific and high-income Western regions would have the lowest. In most region-sex-age groups where the prevalence of raised blood pressure declined, one half or more of the decline was due to the decline in mean blood pressure. Where prevalence of raised blood pressure has increased, the change was entirely driven by increasing mean blood pressure, offset partly by the change in the prevalence-mean association. Conclusions: Change in mean blood pressure is the main driver of the worldwide change in the prevalence of raised blood pressure, but change in the high-blood-pressure tail of the distribution has also contributed to the change in prevalence, especially in older age groups
- …